188 related articles for article (PubMed ID: 32511842)
1. Tumor-Suppressor p53TAD
Dudás EF; Pálfy G; Menyhárd DK; Sebák F; Ecsédi P; Nyitray L; Bodor A
Chembiochem; 2020 Nov; 21(21):3087-3095. PubMed ID: 32511842
[TBL] [Abstract][Full Text] [Related]
2. Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.
Shan B; Li DW; Brüschweiler-Li L; Brüschweiler R
J Biol Chem; 2012 Aug; 287(36):30376-84. PubMed ID: 22807444
[TBL] [Abstract][Full Text] [Related]
3. NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain.
Vise PD; Baral B; Latos AJ; Daughdrill GW
Nucleic Acids Res; 2005; 33(7):2061-77. PubMed ID: 15824059
[TBL] [Abstract][Full Text] [Related]
4. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
5. S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain.
Khan MI; Yuan T; Chou RH; Yu C
PLoS One; 2019; 14(2):e0212299. PubMed ID: 30779808
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
7. Pentamidine inhibit S100A4 - p53 interaction and decreases cell proliferation activity.
Katte RH; Chou RH; Yu C
Arch Biochem Biophys; 2020 Sep; 691():108442. PubMed ID: 32649952
[TBL] [Abstract][Full Text] [Related]
8. Structure Determination of the Transactivation Domain of p53 in Complex with S100A4 Using Annexin A2 as a Crystallization Chaperone.
Ecsédi P; Gógl G; Hóf H; Kiss B; Harmat V; Nyitray L
Structure; 2020 Aug; 28(8):943-953.e4. PubMed ID: 32442400
[TBL] [Abstract][Full Text] [Related]
9. Conformational dynamics of p53 N-terminal TAD2 region under different solvent conditions.
Kumar D; Mishra PM; Gadhave K; Giri R
Arch Biochem Biophys; 2020 Aug; 689():108459. PubMed ID: 32592801
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants governing S100A4-induced isoform-selective disassembly of nonmuscle myosin II filaments.
Kiss B; Kalmár L; Nyitray L; Pál G
FEBS J; 2016 Jun; 283(11):2164-80. PubMed ID: 27029887
[TBL] [Abstract][Full Text] [Related]
11. Multilevel Changes in Protein Dynamics upon Complex Formation of the Calcium-Loaded S100A4 with a Nonmuscle Myosin IIA Tail Fragment.
Pálfy G; Kiss B; Nyitray L; Bodor A
Chembiochem; 2016 Oct; 17(19):1829-1838. PubMed ID: 27418229
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.
Miller Jenkins LM; Feng H; Durell SR; Tagad HD; Mazur SJ; Tropea JE; Bai Y; Appella E
Biochemistry; 2015 Mar; 54(11):2001-10. PubMed ID: 25753752
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
[TBL] [Abstract][Full Text] [Related]
14. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
Okuda M; Nishimura Y
J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into the interaction between p53 TAD1 and AIMP2-DX2 by NMR.
Cho HY; Jha R; Mushtaq AU; Oh SH; Jeon YH
Biochem Biophys Res Commun; 2020 Jun; 527(3):831-838. PubMed ID: 32448505
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form.
Pathuri P; Vogeley L; Luecke H
J Mol Biol; 2008 Oct; 383(1):62-77. PubMed ID: 18783790
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.
Berge G; Mælandsmo GM
Amino Acids; 2011 Oct; 41(4):863-73. PubMed ID: 20177948
[TBL] [Abstract][Full Text] [Related]
18. Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA.
Malashkevich VN; Varney KM; Garrett SC; Wilder PT; Knight D; Charpentier TH; Ramagopal UA; Almo SC; Weber DJ; Bresnick AR
Biochemistry; 2008 May; 47(18):5111-26. PubMed ID: 18410126
[TBL] [Abstract][Full Text] [Related]
19. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
Fadda E; Nixon MG
Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
[TBL] [Abstract][Full Text] [Related]
20. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.
Ha JH; Shin JS; Yoon MK; Lee MS; He F; Bae KH; Yoon HS; Lee CK; Park SG; Muto Y; Chi SW
J Biol Chem; 2013 Mar; 288(10):7387-98. PubMed ID: 23316052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
